Literature DB >> 26220010

Synergistic antidepressant-like effect of ferulic acid in combination with piperine: involvement of monoaminergic system.

Gaowen Li1, Lina Ruan2, Ruijie Chen3, Renye Wang4, Xupei Xie2, Meixi Zhang5, Lichao Chen5, Qizhi Yan2, Miranda Reed6, Jiechun Chen7, Ying Xu2,8, Jianchun Pan9, Wu Huang10.   

Abstract

The lifetime prevalence rate for major depressive disorder (MDD) is approximately 17 % for most developed countries around the world. Dietary polyphenols are currently used as an adjuvant therapy to accelerate the therapeutic efficacy on depression. Ferulic acid (FA) or 4-hydroxy-3-methoxy-cinnamic acid (Fig. 1a) is a main polyphenolic component of Chinese herb Radix Angelicae Sinensis, which is found to have antidepressant-like effects through regulating serotonergic and noradrenergic function. The present study examined the synergistic effect of low doses of FA combined with subthreshold dose of piperine, a bioavailability enhancer, on depression-like behaviors in mice, and investigated the possible mechanism. The administration of FA, even in the highest dose tested, reduced immobility time by 60 % in the tail suspension and forced swimming tests (TST and FST) in mice when compared to control. The maximal antidepressant-like effect of FA was obtained with 200 mg/kg. In addition, piperine only produced a weak antidepressant-like effect in the TST and FST. However, the evidence from the interaction analysis suggested a synergistic effect when low doses of FA were combined with a subthreshold dose of piperine. Further neurochemical evidence such as monoamine levels in the frontal cortex, hippocampus, and hypothalamus and measurements of monoamine oxidase activity also supported a synergistic effect of FA and piperine in the enhancement of monoaminergic function. This finding supports the concept that the combination strategy might be an alternative therapy in the treatment of psychiatric disorders with high efficacy and low side effects.

Entities:  

Keywords:  Depression; Ferulic acid; MAO; Monoamines; Piperine

Mesh:

Substances:

Year:  2015        PMID: 26220010      PMCID: PMC4795470          DOI: 10.1007/s11011-015-9704-y

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  27 in total

1.  Enhancing the bioavailability of resveratrol by combining it with piperine.

Authors:  Jeremy J Johnson; Minakshi Nihal; Imtiaz A Siddiqui; Cameron O Scarlett; Howard H Bailey; Hasan Mukhtar; Nihal Ahmad
Journal:  Mol Nutr Food Res       Date:  2011-06-29       Impact factor: 5.914

2.  Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats.

Authors:  Ying Xu; Bao-Shan Ku; Hai-Yan Yao; Yan-Hua Lin; Xing Ma; Yong-He Zhang; Xue-Jun Li
Journal:  Pharmacol Biochem Behav       Date:  2005-09       Impact factor: 3.533

3.  Curcumin immune-mediated and anti-apoptotic mechanisms protect against renal ischemia/reperfusion and distant organ induced injuries.

Authors:  Azza S Awad; Amany A El-Sharif
Journal:  Int Immunopharmacol       Date:  2011-02-24       Impact factor: 4.932

4.  Ferulic acid-induced anti-depression and prokinetics similar to Chaihu-Shugan-San via polypharmacology.

Authors:  Ying-jin Zhang; Xi Huang; Yang Wang; Ying Xie; Xin-jiang Qiu; Ping Ren; Li-chen Gao; Hong-hao Zhou; Hui-yun Zhang; Ming-Qi Qiao
Journal:  Brain Res Bull       Date:  2011-07-20       Impact factor: 4.077

5.  Modulation of monoamine oxidase activity in different brain regions and platelets following exposure of rats to methylmercury.

Authors:  S K Chakrabarti; K M Loua; C Bai; H Durham; J C Panisset
Journal:  Neurotoxicol Teratol       Date:  1998 Mar-Apr       Impact factor: 3.763

6.  Antidepressant-like effect of the methanolic extract from Bupleurum falcatum in the tail suspension test.

Authors:  Sunoh Kwon; Bombi Lee; Myunghwan Kim; Hyejung Lee; Hi-Joon Park; Dae-Hyun Hahm
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-11-22       Impact factor: 5.067

7.  Antidepressant-like effect of low molecular proanthocyanidin in mice: involvement of monoaminergic system.

Authors:  Ying Xu; Shan Li; Ruijie Chen; Gaowen Li; Philip A Barish; Wenting You; Ling Chen; Mengmeng Lin; Baoshan Ku; Jianchun Pan; William O Ogle
Journal:  Pharmacol Biochem Behav       Date:  2009-10-23       Impact factor: 3.533

8.  The tail suspension test: a new method for screening antidepressants in mice.

Authors:  L Steru; R Chermat; B Thierry; P Simon
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 9.  Sirtuins: novel targets for metabolic disease.

Authors:  Peter J Elliott; Michael Jirousek
Journal:  Curr Opin Investig Drugs       Date:  2008-04

10.  Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes.

Authors:  Mohit Kumar Bhutani; Mahendra Bishnoi; Shrinivas K Kulkarni
Journal:  Pharmacol Biochem Behav       Date:  2008-10-25       Impact factor: 3.533

View more
  10 in total

Review 1.  A Review on Potential Footprints of Ferulic Acid for Treatment of Neurological Disorders.

Authors:  Surabhi Thapliyal; Tanveer Singh; Shailendra Handu; Manisha Bisht; Puja Kumari; Priyanka Arya; Pallavi Srivastava; Ravi Gandham
Journal:  Neurochem Res       Date:  2021-02-05       Impact factor: 3.996

Review 2.  The Current Situation on Major Depressive Disorder in China: Research on Mechanisms and Clinical Practice.

Authors:  Zhenghua Hou; Wenhao Jiang; Yingying Yin; Zhijun Zhang; Yonggui Yuan
Journal:  Neurosci Bull       Date:  2016-05-30       Impact factor: 5.203

3.  Ferulic Acid Supplementation for Management of Depression in Epilepsy.

Authors:  Tanveer Singh; Taranjot Kaur; Rajesh Kumar Goel
Journal:  Neurochem Res       Date:  2017-06-12       Impact factor: 3.996

4.  Piperine potentiates the effects of trans-resveratrol on stress-induced depressive-like behavior: involvement of monoaminergic system and cAMP-dependent pathway.

Authors:  Ying Xu; Chong Zhang; Feiyan Wu; Xiaoxiao Xu; Gang Wang; Mengmeng Lin; Yingcong Yu; Yiran An; Jianchun Pan
Journal:  Metab Brain Dis       Date:  2016-03-05       Impact factor: 3.584

5.  Enhanced anti-tumor efficacy and mechanisms associated with docetaxel-piperine combination- in vitro and in vivo investigation using a taxane-resistant prostate cancer model.

Authors:  Chenrui Li; Zhijun Wang; Qian Wang; Rebecca Lucinda Ka Yan Ho; Ying Huang; Moses S S Chow; Christopher Wai Kei Lam; Zhong Zuo
Journal:  Oncotarget       Date:  2017-12-14

Review 6.  The Neuroprotective Effects of Phenolic Acids: Molecular Mechanism of Action.

Authors:  Dominik Szwajgier; Kamila Borowiec; Katarzyna Pustelniak
Journal:  Nutrients       Date:  2017-05-10       Impact factor: 5.717

Review 7.  Antidepressant Potential of Cinnamic Acids: Mechanisms of Action and Perspectives in Drug Development.

Authors:  Lúcio Ricardo Leite Diniz; Marilia Trindade de Santana Souza; Joice Nascimento Barboza; Reinaldo Nóbrega de Almeida; Damião Pergentino de Sousa
Journal:  Molecules       Date:  2019-12-06       Impact factor: 4.411

8.  Evaluation and comparison of the antidepressant-like activity of Artemisia dracunculus and Stachys lavandulifolia ethanolic extracts: an in vivo study.

Authors:  Reza Jahani; Dariush Khaledyan; Ali Jahani; Elham Jamshidi; Mohammad Kamalinejad; Mona Khoramjouy; Mehrdad Faizi
Journal:  Res Pharm Sci       Date:  2019-12-11

Review 9.  Dietary Plant Polyphenols as the Potential Drugs in Neurodegenerative Diseases: Current Evidence, Advances, and Opportunities.

Authors:  Lu Yan; Min-Song Guo; Yue Zhang; Lu Yu; Jian-Ming Wu; Yong Tang; Wei Ai; Feng-Dan Zhu; Betty Yuen-Kwan Law; Qi Chen; Chong-Lin Yu; Vincent Kam-Wai Wong; Hua Li; Mao Li; Xiao-Gang Zhou; Da-Lian Qin; An-Guo Wu
Journal:  Oxid Med Cell Longev       Date:  2022-02-21       Impact factor: 6.543

Review 10.  The Gut Microbiota Links Dietary Polyphenols With Management of Psychiatric Mood Disorders.

Authors:  Susan Westfall; Giulio Maria Pasinetti
Journal:  Front Neurosci       Date:  2019-11-05       Impact factor: 4.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.